Description
Detects genetic variations in HLA-B*1502 and CYP2C9 to assess the risk of adverse reactions to phenytoin, a drug used to control seizures.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.